Elevated circulating levels and tissue expression of pentraxin 3 in uremia: a reflection of endothelial dysfunction.
about
The inflammatory protein Pentraxin 3 in cardiovascular diseaseThree-month variation of plasma pentraxin 3 compared with C-reactive protein, albumin and homocysteine levels in haemodialysis patients.Evaluation of the association of plasma pentraxin 3 levels with type 2 diabetes and diabetic nephropathy in a Malay populationEffects of 6 months of resveratrol versus placebo on pentraxin 3 in patients with type 2 diabetes mellitus: a double-blind randomized controlled trial.Acute phase proteins as promising biomarkers: Perspectives and limitations for human and veterinary medicine.Correlation between arterial stiffness and inflammatory markers in autosomal dominant polycystic kidney disease patients with preserved renal function.Novel association between serum pentraxin-2 levels and advanced fibrosis in well-characterised patients with non-alcoholic fatty liver disease.Inflammatory biomarker pentraxin 3 (PTX3) in relation to obesity, body fat depots and weight loss.Neutrophil-dependent pentraxin-3 and reactive oxygen species production modulate endothelial dysfunction in haemodialysis patients.Altered Protein Composition of Subcutaneous Adipose Tissue in Chronic Kidney Disease.Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update.PTX3 in serum induces renal mesangial cell proliferation but has no effect on apoptosis.Association of genetic variants of pentraxin 3 rs3816527 with hypertension in Chronic kidney disease patients.Hemodialysis Induces an Acute Decline in Cerebral Blood Flow in Elderly Patients.Relationship between plasma pentraxin 3 level and risk of chronic kidney disease in the Korean elderly: the Dong-gu study.Inflammation down-regulates CYP3A4-catalysed drug metabolism in hemodialysis patients.
P2860
Q26738957-12D8DC54-C647-4A7A-A9BE-919F8F9F720CQ35227705-D0F164CB-5506-491C-B5FE-B862928D371FQ37370584-FE5DF674-CE71-4B81-B299-E66A4385218AQ38380295-6065F958-0B9C-42C3-B8DE-985D62B41C0EQ38858633-651DAD91-821A-430F-8CB3-79538F36E72DQ40865321-B028B093-A3D2-488E-961B-8A690938C608Q41633785-C35AA05B-0DE7-469F-A7CA-05F4CC172123Q46237239-A1BB02A8-EAF0-47CD-89AA-BCA8179DA4A9Q46450702-317BA2FC-DD76-49AE-8B50-0F59EBC0CC5AQ47099742-71C9D0C7-7876-495E-90E8-BBAFED848F19Q47216784-20650548-50AA-4264-8799-C425228D89A6Q49400168-8D04CE5C-23BB-4F4D-84FD-0E2E857F7878Q51067081-37D51147-1889-4AC0-821F-E29B835A2D5EQ51745562-B5615CD6-3BB5-4BEF-8C73-0A728D7AB23BQ52761490-C5D03D6A-B6B1-4D2A-8A20-1982630E3312Q55439721-1C3474CD-973C-49FA-AFEA-B135AA595D84
P2860
Elevated circulating levels and tissue expression of pentraxin 3 in uremia: a reflection of endothelial dysfunction.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Elevated circulating levels an ...... on of endothelial dysfunction.
@ast
Elevated circulating levels an ...... on of endothelial dysfunction.
@en
Elevated circulating levels an ...... on of endothelial dysfunction.
@nl
type
label
Elevated circulating levels an ...... on of endothelial dysfunction.
@ast
Elevated circulating levels an ...... on of endothelial dysfunction.
@en
Elevated circulating levels an ...... on of endothelial dysfunction.
@nl
prefLabel
Elevated circulating levels an ...... on of endothelial dysfunction.
@ast
Elevated circulating levels an ...... on of endothelial dysfunction.
@en
Elevated circulating levels an ...... on of endothelial dysfunction.
@nl
P2093
P2860
P50
P1433
P1476
Elevated circulating levels an ...... ion of endothelial dysfunction
@en
P2093
Anna Witasp
Erik Näslund
Folke Hammarqvist
Louise Nordfors
Mikael Rydén
Samsul Arefin
P2860
P304
P356
10.1371/JOURNAL.PONE.0063493
P407
P577
2013-05-03T00:00:00Z